Efficacy of a combination of cholesterol absorption and synthesis inhibitors in the correction of hyperlipidemia and dietary fat intolerance in patients with coronary heart disease (ESTHETICS trial)
- 作者: Bubnova M.1, Perova N.1, Aronov D.1, Zeinapur A.1, Ozerova I.1
-
隶属关系:
- State Research Center for Preventive Medicine, Ministry of Health of the Russian Federation
- 期: 卷 4, 编号 1 (2013)
- 页面: 35-43
- 栏目: Articles
- URL: https://journals.rcsi.science/2221-7185/article/view/45016
- DOI: https://doi.org/10.26442/CS45016
- ID: 45016
如何引用文章
全文:
详细
作者简介
M. Bubnova
State Research Center for Preventive Medicine, Ministry of Health of the Russian Federation
Email: mbubnova@gnicpm.ru
д-р мед. наук, проф., рук. отд. реабилитации и вторичной профилактики сочетанной патологии с лабораторией профилактики атеросклероза и тромбоза ФГБУ ГНИЦ ПМ Минздрава РФ
N. Perova
State Research Center for Preventive Medicine, Ministry of Health of the Russian Federationд-р мед. наук, проф., вед. науч. сотр. отд. изучения биохимических маркеров хронических неинфекционных заболеваний ФГБУ ГНИЦ ПМ Минздрава РФ
D. Aronov
State Research Center for Preventive Medicine, Ministry of Health of the Russian Federationд-р мед. наук, проф., засл. деят. науки РФ, рук. лаб. кардиологической реабилитации ФГБУ ГНИЦ ПМ Минздрава РФ
A. Zeinapur
State Research Center for Preventive Medicine, Ministry of Health of the Russian Federationканд. мед. наук, зав. приемным отд-нием ФГБУ ГНИЦ ПМ Минздрава РФ
I. Ozerova
State Research Center for Preventive Medicine, Ministry of Health of the Russian Federationканд. биол. наук, вед. науч. сотр. отд. изучения биохимических маркеров хронических неинфекционных заболеваний ФГБУ ГНИЦ ПМ Минздрава РФ
参考
- Бокерия Л.А., Гудкова Р.Г. Сердечно - сосудистая хирургия. М.: НЦССХ им. А.Н.Бакулева РАМН, 2010.
- Zilversmit D.B. Atherogenesis: a postprandial phenomenon. Circulation 1979; 60: 473–84.
- Mamo J.C.L., Proctor S.D., Smith D. Retention of chylomicron remnants by arterial tissue; importance of an efficient clearance mechanism from plasma. Atherosclerosis 1998; 141 (Suppl. 1): S63–S9.
- Бубнова М.Г., Аронов Д.М., Перова Н.В., Мазаев В.П. Связь уровня липемии после жировой нагрузки с выраженностью атеросклероза коронарных артерий. Терапевт. арх. 2004; 76 (6): 62–7.
- Бубнова М.Г., Оганов Р.Г. Нарушенная толерантность к пищевым жирам и ее значение в атеротромбогенезе. Терапевт. арх. 2004; 76 (1): 73–8.
- Havel R.J. Postprandial hyperlipidemia and remnant lipoproteins. Curr Opin Lipidol 1994; 5: 102–9.
- Erkelens D.W. Man is a postprandial subject and postprandial triglyceride - rich lipoprotein remnants are atherogenic. Nutr Metab Cardiovac Dis 1993; 3: 99–101.
- Davignon J, Cohn J. Triglycerides: a risk factor for coronary heart disease (Review). Atherosclerosis 1996; 124 (Suppl. 1): S57–S64.
- Patsch J.R., Hopferwieser T, Muhlberger V. et al. Postprandial lipemia in patients with coronary artery disease. Circulation 1990; 82 (Suppl.III): S284.
- Patsch J.R., Miesenbock G., Hopferwieser T. et al. Relation of triglyceride metabolism and coronary artery disease: studies in the postprandial state. Arterioscler Thromb 1992; 12: 1336–45.
- Steiner G. Triglyceride - rich lipoproteins and atherosclerosis, from fast to feast. Ann Med 1993; 25: 431–5.
- Chapman M.J., Ginsberg H.N., Amarenco P. et al. Triglyceride - rich lipoproteins and high - density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J 2011; 32: 1345–61.
- Weintraub M.S., Grosskopf I, Rassin T. et al. Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years. Br Med J 1996; 312: 936–9.
- Karpe F, Steiner G, Uffelman K et al. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994; 106: 83–97.
- Бубнова М.Г., Перова Н.В., Аронов Д.М. и др. Синдром нарушенной толерантности к экзогенным (пищевым) жирам при коронарной болезни сердца. Кардиология. 2003; 4: 36–42.
- Twickler T.B., Dallinga-Thie G.M., de Valk H.W. et al. High dose of simvastatin normalized postprandial remnant - like particle response in patients with heterozygous familian hypercholesterolaemia. Atherosclerosis Thrombavasc Biol 2000; 20: 2422–7.
- De Sauvage Nolting P, Dalligna-Thie G, Twickler T.B., Kastelein J.P. Elevated fasting remnant - like particles in heterozygous familian hypercholesterolaemia and response to simvastatin 80 mg.XIV Intern. Simp. Drugs Effecting Lipid Metabolism, New York 2001; 32 (abstract).
- Van Heek M, Compton D.S., Davis H.R. The cholesterol absorption inhibitor ezetimibe, decrease diet - induced hypercholesterolaemia in monkeys. Eur J Pharmacol 2001; 415 (1): 79–84.
- Altmann S.W., Davis H.R. J, Zhu L.J. et al. Niemann–Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Sci 2004; 303: 1201–4.
- Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults.JAMA 1993; 269: 3015–23.
- Patch J.R., Miesenbock G, Hopferwieser T. et al. Relation of triglyceride metabolism and coronary artery disease: studies in the postprandial state. Arteriosc Thromb 1992; 12: 1336–45.
- Bays H.E., Moore P.B., Drehobl M.A. et al. Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies. Clin Ther 2001; 23: 1209–30.
- Ezzet F, Wexler D, Statkevich P et al. The plasma concentration and LDL-C relationship in patients receiving ezetimibe. J Clin Pharmacol 2001; 41 (9): 943–9.
- Knoop R.H., Gitter H, Truitt T. et al. Ezetimibe Study Group. Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolaemia. Eur Heart J 2003; 24 (8): 729–41.
- Knoop R.H., Dujovane C.A., Le Beaut A. et al. Ezetimibe Study Group. Evaluation of the efficacy, safety, and tolerability of ezetimibe in primary hypercholesterolemia: a pooled analysis from two controlled phase III clinical studies. Int J Clin Pract 2003; 57 (5): 363–8.
- Аронов Д.М. Одновременное ингибирование всасывания и синтеза холестерина при сочетанном применении эзетимиба и симвастатина. Кардиовскулярная терапия и профилактика. 2005; 4: 91–100.
- Davidson M.H., McGarry T, Bettis R. et al. Ezetimibe coadministred with primary hypercholesterolaemia.JACC 2002;40 (12): 2125–34.
- Baigent C, Landray M, Reith C et al. The effect of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomized placebo - controlled trial. Published online June 9, 2011.
- De Bari O, Neuschwander-Tetri B.A., Liu M. et al. Ezetimibe: Its novel effect on the prevention and the treatment of cholesterol gallstones and nonalcoholic fatty lever disease. J Lipids 2012; Article ID 302847, 16 pages doi: 10.1155/2012/302847
- Davis H.R. Jr, Compton D.S., Hoos L, Tetzloff G. Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in Apo-E knockout mice. Arterioscler Thromb Vasc Biol 2001; 21: 2032–8.
- Krauss R.M., Williams P.T., Brensike J. et al. Intermediate - density lipoproteins and progression of coronary artery disease in hypercholesterolemic men. Lancet 1987; 2: 62–6.
- Miettinen .TA. Cholesterol absorption inhibition: a strategy for cholesterol - lowering therapy. Int J Clin Pract 2001; 55 (10): 710–6.
- Перова Н.В., Бубнова М.Г., Аронов Д.М. и др. Влияние ловастатина на концентрацию липидов и аполипопротеинов сыворотки крови после алиментарной жировой нагрузки у больных ишемической болезнью сердца. Кардиология. 1993; 4: 8–10.
- Бубнова М.Г., Аронов Д.М., Перова Н.В. и др. Правастатин в коррекции атерогенной экзогенно - индуцированной постпрандиальной гиперлипидемии. Кардиология. 2002; 1; 27–32.
- Ose L, Bays H.E., Eraser N. et al. Ezetimibe/Simvastatin Therapy is more effective than simvastatin alone at reducing in remnant - like particle cholesterol.MSD, Schering-Pough.
![](/img/style/loading.gif)